Targeted Therapies in Hematologic Oncology: the crucial Role of Molecular Biomarkers

The treatment paradigm for hematologic malignancies has shifted undoubtedly over the past two decades. What was once a largely histomorphology-driven discipline has become one of the most molecularly stratified fields in oncology, where genomic characterization at diagnosis is not merely informative but functionally essential. Treatment eligibility, sequencing, intensity, and response assessment are all anchored to […]

logo Diatech Pharmacogenetics

Subscribe to Our Newsletter

You are leaving the U.S. & Canada Research Use Only (RUO) area.

The content you are about to access is intended for other markets and may include products or information not available in the U.S. or Canada.

logo Diatech Pharmacogenetics
Select Your Region

Please select your region to access the content that is most relevant to your location and applicable regulations.